Specification:
|
|
CP05
|
CP10
|
EP6
|
USP32
|
Low Acid
|
Water Soluble
|
|
Ginkgo-flavone Glycosides
|
≥24%
|
≥24%
|
22-27%
|
22-27%
|
≥24%
|
≥24%
|
|
Quercetin/Kaempferol
|
0.8—1.5
|
0.8—1.2
|
0.8—1.2
|
0.8—1.2
|
0.8—1.2
|
0.8—1.2
|
|
Isorhamnetin/Quercetin
|
|
|
≥0.15
|
|
|
|
|
Total terpene lactones
|
≥6%
|
≥6%
|
5.4-6.6%
|
5.4-12%
|
≥6%
|
≥6%
|
|
Ginkgol ides A+B+C
|
|
|
2.8-3.4%
|
2.8-6.2%
|
|
|
|
Bilobalides
|
|
|
2.6-3.2%
|
2.6-5.8%
|
|
|
|
Ginkgolic Acid
|
≤10ppm
|
≤10ppm
|
≤5ppm
|
≤5ppm
|
≤1ppm
|
≤5ppm
|
|
water solubility
|
|
|
|
|
|
≥99%
|
Loss On Drying：≤ 5.0%
Sulphate Ash： ≤0.8%
Heavy Metal： ≤ 20ppm
Package：25kg/drum ，upon client's require
Arsenic ：<1 ppm
pesticide residue ：≤10ppm
Residual solvent： ≤10ppm
Total Bacterial Count： ≤1000CFU/G
E. coli ：Negative
Pseudomonas aeruginosa ：Negative
Staphylococcus ：Negative
Pharmacological action: 1.Blood flow amel ioration, increasing brain blood- supply 2. Blood fat and dense amelioration；anti cardiovascular disease 3. Anti aging, eliminate free radical 4. Remember amelioration, activate thinking ability 5. Eliminate hands-feet anaesthesia 6. Blood pressure regulation
|
